View in EDS HTML Full Text PDF Full Text

Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.

Saved in:
Bibliographic Details
Title: Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.
Authors: McGonigle, Rylee1,2 (AUTHOR), Naci, Huseyin3 (AUTHOR), Siebert, Maximilian1 (AUTHOR), Ouvina, Michelle1,2 (AUTHOR), Gutiérrez-Sacristán, Alba4 (AUTHOR), Wagner, Anita K.5 (AUTHOR), Bourgeois, Florence T.1,2,6 (AUTHOR) florence.bourgeois@childrens.harvard.edu
Source: PLoS Medicine. 12/17/2025, Vol. 22 Issue 12, p1-15. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 190297078
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22McGonigle%2C+Rylee%22">McGonigle, Rylee</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Naci%2C+Huseyin%22">Naci, Huseyin</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Siebert%2C+Maximilian%22">Siebert, Maximilian</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ouvina%2C+Michelle%22">Ouvina, Michelle</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gutiérrez-Sacristán%2C+Alba%22">Gutiérrez-Sacristán, Alba</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wagner%2C+Anita+K%2E%22">Wagner, Anita K.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bourgeois%2C+Florence+T%2E%22">Bourgeois, Florence T.</searchLink><relatesTo>1,2,6</relatesTo> (AUTHOR)<i> florence.bourgeois@childrens.harvard.edu</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22PLoS+Medicine%22">PLoS Medicine</searchLink>. 12/17/2025, Vol. 22 Issue 12, p1-15. 15p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=190297078
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.pmed.1004651
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 15
        StartPage: 1
    Titles:
      – TitleFull: Pediatric studies and labeling additions required by the U.S. FDA for novel drugs approved from 2011 to 2023: A retrospective cohort study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: McGonigle, Rylee
      – PersonEntity:
          Name:
            NameFull: Naci, Huseyin
      – PersonEntity:
          Name:
            NameFull: Siebert, Maximilian
      – PersonEntity:
          Name:
            NameFull: Ouvina, Michelle
      – PersonEntity:
          Name:
            NameFull: Gutiérrez-Sacristán, Alba
      – PersonEntity:
          Name:
            NameFull: Wagner, Anita K.
      – PersonEntity:
          Name:
            NameFull: Bourgeois, Florence T.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 12
              Text: 12/17/2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 15491277
          Numbering:
            – Type: volume
              Value: 22
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: PLoS Medicine
              Type: main
ResultId 1